RHC
The drug Heberprot P continues to be the only one of its kind and very effective, 17 years after its registration in the Cuban health registry, with encouraging results in the treatment of diabetic foot.
The Center for Genetic Engineering and Biotechnology, on its Twitter account, recalled that it is an innovative and very effective biotechnological medicine.
The president of the Business Group of the Biotechnological and Pharmaceutical Industries of Cuba (BioCubaFarma), Eduardo Martínez, declared to the magazine ‘Avances Médicos’, of Prensa Latina, that there is still no other product in the world like this.
Heberprot P is the only one in the world capable of stimulating granulation and accelerated re-epithelialization in diabetic foot ulcers and reduces the healing time of these lesions, thereby reducing the number of debridements and the risk of amputation.